You are here: Home » News-CM » Companies » News
Business Standard

Hikal receives EIR for API unit at Jigani, Bangalore

Capital Market 

Hikal announced it has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for its API Unit located at Jigani, Bangalore for the inspection conducted in July 2019.

The inspection resulted in one minor FDA Form 483 which was closed out immediately.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, November 04 2019. 13:52 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU